Polymyxins in 2015: it's like déjà vu all over again.
作者信息
Pogue Jason M, Rotschafer John C
机构信息
Department of Pharmacy Services, Sinai-Grace Hospital, Detroit Medical Center, Detroit, Michigan; Wayne State University School of Medicine, Detroit, Michigan.
出版信息
Pharmacotherapy. 2015 Jan;35(1):9-10. doi: 10.1002/phar.1543.
PMID:25630410
Abstract
摘要
相似文献
1
Polymyxins in 2015: it's like déjà vu all over again.2015年的多粘菌素：感觉似曾相识。
Pharmacotherapy. 2015 Jan;35(1):9-10. doi: 10.1002/phar.1543.
2
Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing.临床优化多黏菌素使用的考虑因素：重点关注药物选择和剂量。
Clin Microbiol Infect. 2017 Apr;23(4):229-233. doi: 10.1016/j.cmi.2017.02.023. Epub 2017 Feb 24.
3
[Aminoglycosides and polymyxins].[氨基糖苷类和多粘菌素]
Enferm Infecc Microbiol Clin. 2009 Mar;27(3):178-88. doi: 10.1016/j.eimc.2009.02.001.
4
Adverse reactions associated with systemic polymyxin therapy.与全身性多粘菌素治疗相关的不良反应。
Pharmacotherapy. 2015 Jan;35(1):28-33. doi: 10.1002/phar.1493. Epub 2014 Sep 30.
5
Intravenous polymyxins: Revival with puzzle.静脉注射多黏菌素：困境中的复兴。
Biosci Trends. 2017;11(4):370-382. doi: 10.5582/bst.2017.01188.
6
Colistin: understanding and applying recent pharmacokinetic advances.黏菌素：理解与应用近期的药代动力学进展
Pharmacotherapy. 2015 Jan;35(1):11-6. doi: 10.1002/phar.1484. Epub 2014 Sep 3.
7
Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins?是否有办法规避多黏菌素类药物的肾毒性？
Int J Antimicrob Agents. 2016 Dec;48(6):622-626. doi: 10.1016/j.ijantimicag.2016.11.001. Epub 2016 Nov 11.
8
Pediatric antimicrobial therapy IV.儿科抗菌治疗四。
Can Med Assoc J. 1973 Aug 18;109(4):309-10.
9
Multidrug-resistant gram-negative infections. Bringing back the old.多重耐药革兰氏阴性菌感染。重拾旧法。
Crit Care Nurs Q. 2011 Apr-Jun;34(2):87-100. doi: 10.1097/CNQ.0b013e31820f6e88.
10
[Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].[囊性纤维化中的抗假单胞菌雾化治疗：妥布霉素的疗效改善]
Rev Pneumol Clin. 2002 Jun;58(3 Pt 1):131-8.
Zotero 插件